Tech players in healthcare, finance sectors should have no excuses for falling foul of regulators
Being unsure or not knowing is no justification when operating in regulated industries
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[SINGAPORE] Tech startups typically receive some leeway from regulators, so as not to snuff out innovation. But for those operating in highly regulated sectors such as healthcare and finance, there should certainly be a higher bar. And technology providers in these sectors should not hope to be shielded from the regulators’ gaze.
A case in point is the Ministry of Health’s (MOH) recent admonishment of telemedicine platform MaNaDr. MOH had stripped MaNaDr of its clinic licence in December last year, after investigations uncovered short teleconsultations of a minute or less and case notes that were sparse and brief. MaNaDr would go on to close its clinic on Dec 24, 2024.
But in a briefing on Apr 2, MaNaDr sought to distance itself from its clinic business and instead focus on its role as a tech platform.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Why where you park your joint venture matters: Lessons from a US$689 million shareholder dispute
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Singaporeans can now buy record amount of yen per Singdollar